Figure 3. 10-year CHD risk levels at which the number of
cardiovascular disease events prevented is closely balanced
to the number of serious bleeding events
Shared decision making is strongly encouraged with persons whose risk is
close to (either above or below) these estimates of 10-year risk levels. As
the potential cardiovascular disease reduction benefit increases above
harms, the recommendation to take aspirin should become stronger.
| Men |
Women |
| Age |
10-Year
CHD Risk, % |
Age |
10-Year
Stroke Risk, % |
| 45–59 y |
≥4 |
55–59 y | ≥3 |
| 60–69 y |
≥9 |
60–69 y | ≥8 |
| 70–79 y |
≥12 |
70–79 y | ≥11 |
CHD = coronary heart disease.
Return to Document